AAAAAA
Results: 1-25/27
Authors:
McDonald, R
Haycox, A
Walley, T
Citation: R. Mcdonald et al., The impact of health economics on healthcare delivery - The health economists' perspective, PHARMACOECO, 19(8), 2001, pp. 803-809
Authors:
Hughes, DA
Walley, T
Citation: Da. Hughes et T. Walley, Economic evaluations during early (phase II) drug development - A role forclinical trial simulations?, PHARMACOECO, 19(11), 2001, pp. 1069-1077
The impact of non-compliance on the cost-effectiveness of pharmaceuticals:A review of the literature
Authors:
Hughes, DA
Bagust, A
Haycox, A
Walley, T
Citation: Da. Hughes et al., The impact of non-compliance on the cost-effectiveness of pharmaceuticals:A review of the literature, HEALTH ECON, 10(7), 2001, pp. 601-615
Authors:
Unsworth, L
Walley, T
Citation: L. Unsworth et T. Walley, Trends in primary care antibiotic prescribing in England 1994-1998, PHARMA D S, 10(4), 2001, pp. 309-314
Authors:
Cranney, M
Warren, E
Barton, S
Gardner, K
Walley, T
Citation: M. Cranney et al., Why do GPs not implement evidence-based guidelines? A descriptive study, FAM PRACT, 18(4), 2001, pp. 359-363
Authors:
Folino-Gallo, P
Walley, T
Frolich, JC
Carvajal, A
Edwards, IR
Citation: P. Folino-gallo et al., Availability of medicines in the European Union: results from the EURO-Medicines project, EUR J CL PH, 57(6-7), 2001, pp. 441-446
Authors:
Bagust, A
Walley, T
Citation: A. Bagust et T. Walley, An alternative to body mass index for standardizing body weight for stature, QJM-MON J A, 93(9), 2000, pp. 589-596
Authors:
Walley, T
Murphy, M
Codd, M
Johnston, Z
Quirke, T
Citation: T. Walley et al., Effects of a monetary incentive on primary care prescribing in Ireland: Changes in prescribing patterns in one health board 1990-1995, PHARMA D S, 9(7), 2000, pp. 591-598
Authors:
Walley, T
Roberts, D
Citation: T. Walley et D. Roberts, Average daily quantities: A tool for measuring prescribing volume in England, PHARMA D S, 9(1), 2000, pp. 55-58
Authors:
Walley, T
Earl-Slater, A
Haycox, A
Bagust, A
Citation: T. Walley et al., An integrated national pharmaceutical policy for the United Kingdom?, BR MED J, 321(7275), 2000, pp. 1523-1526
Authors:
Gilbert, D
Walley, T
New, B
Citation: D. Gilbert et al., Lifestyle medicines, BR MED J, 321(7272), 2000, pp. 1341-1344
Authors:
Strobl, J
Cave, E
Walley, T
Citation: J. Strobl et al., Data protection legislation: interpretation and barriers to research, BR MED J, 321(7265), 2000, pp. 890-892
Authors:
Walley, T
Burrill, P
Citation: T. Walley et P. Burrill, Generic prescribing: time to regulate the market? Price rises are a blow to nascent primary care groups, BR MED J, 320(7228), 2000, pp. 131-132
Authors:
Walker, PD
Walley, T
Citation: Pd. Walker et T. Walley, Feasibility study of multicentre comparison of NHS hospital pharmacy computer data, BR J CL PH, 50(1), 2000, pp. 48-54
Authors:
Duerden, M
Walley, T
Citation: M. Duerden et T. Walley, Prescribing at the interface between primary and secondary care in the UK - Towards joint formularies?, PHARMACOECO, 15(5), 1999, pp. 435-443
Authors:
Wilson, RPH
Hatcher, J
Barton, S
Walley, T
Citation: Rph. Wilson et al., The association of some practice characteristics with antibiotic prescribing, PHARMA D S, 8(1), 1999, pp. 15-21
Authors:
Cranney, M
Barton, S
Walley, T
Citation: M. Cranney et al., Addressing barriers to change: an RCT of practice-based education to improve the management of hypertension in the elderly, BR J GEN PR, 49(444), 1999, pp. 522-526
Authors:
Wilson, RPH
Hatcher, J
Barton, S
Walley, T
Citation: Rph. Wilson et al., Therapeutic substitution and therapeutic conservatism as cost-containment strategies in primary care: a study of fundholders and non-fundholders, BR J GEN PR, 49(443), 1999, pp. 431-435
Authors:
Haycox, A
Bagust, A
Walley, T
Citation: A. Haycox et al., Importance of health economics must be recognised when trials are designed, BR MED J, 318(7199), 1999, pp. 1696-1697
Authors:
Haycox, A
Bagust, A
Walley, T
Citation: A. Haycox et al., Clinical guidelines - the hidden costs, BR MED J, 318(7180), 1999, pp. 391-393
Authors:
Haycox, A
Barton, S
Walley, T
Citation: A. Haycox et al., Treatment of gastro-oesophageal reflux disease in adults - "Step down" strategy of treatment would be expensive, BR MED J, 318(7175), 1999, pp. 59-59
Authors:
Walley, T
Citation: T. Walley, Why health economics matter, J DERM TR, 10, 1999, pp. S3-S7
Authors:
Vilar, FJ
Khoo, SH
Walley, T
Citation: Fj. Vilar et al., The management of Pneumocystis carinii pneumonia, BR J CL PH, 47(6), 1999, pp. 605-609
Authors:
Freemantle, N
Eccles, M
Wood, J
Mason, J
Nazareth, I
Duggan, C
Young, P
Haines, A
Drummond, M
Russell, I
Walley, T
Citation: N. Freemantle et al., A randomized trial of Evidence-based OutReach (EBOR): Rationale and design, CONTR CL TR, 20(5), 1999, pp. 479-492
Authors:
Hughes, DA
Woodcock, A
Walley, T
Citation: Da. Hughes et al., Review of therapeutically equivalent alternatives to short acting beta(2) adrenoceptor agonists delivered via chlorofluorocarbon-containing inhalers, THORAX, 54(12), 1999, pp. 1087-1092